Department of Otolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Department of Otolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Otolaryngology, Head and Neck Surgery, Xiamen Chang Gung Hospital, Xiamen, China.
Am J Otolaryngol. 2020 Nov-Dec;41(6):102654. doi: 10.1016/j.amjoto.2020.102654. Epub 2020 Aug 5.
Chronic rhinosinusitis with nasal polyposis (CRSwNP) remains a difficult-to-cure disease. The aim of this study was to determine the potential long-term predictors of revision sinus surgery for CRSwNP.
Prospectively gathered patients with bilateral CRSwNP who received primary endoscopic sinus surgery were enrolled. Clinical variables, including the preoperative Lund-Mackay score (LMS), were collected to clarify possible risk factors for revision surgery within a 5-year follow-up. The symptomatic burden was measured using a 10-cm visual analog scale (VAS) before and 1 year after surgery. Further survival analysis was performed to present the revision-free survival in Kaplan-Meier plotting.
Eighty four qualified patients were identified and all of them experienced significant improvement in VAS after primary surgery. The 5-year revision rate was 19.05%, and the mean time of revision surgery was 25.31 ± 17.11 months postoperatively. Nasal allergy (OR = 9.287; p = 0.011) and LMS (OR = 1.29; p = 0.06) were found to be the independent risk factors for revision surgery. The discriminatory power of LMS for revision surgery was acceptable (AUC = 0.79) with the best cutoff point located at LMS > 13.5. Patients with both nasal allergy and LMS≧14 had only half of revision-free survival in comparison to overall survival (38.1% vs. 80.95%, p < 0.001).
In patients with CRSwNP who have concurrent nasal allergy and higher preoperative LMS may indicate an advanced disease status and eventually be in a high risk of revision surgery after a long-term follow-up. An outcome-based staging system will be helpful in the future to improve the prognosis for CRSwNP.
慢性鼻-鼻窦炎伴鼻息肉(CRSwNP)仍然是一种难以治愈的疾病。本研究旨在确定 CRSwNP Revision 鼻窦手术的潜在长期预测因素。
前瞻性纳入双侧 CRSwNP 接受初次内镜鼻窦手术的患者。收集临床变量,包括术前 Lund-Mackay 评分(LMS),以明确 5 年随访内 Revision 手术的可能危险因素。使用 10cm 视觉模拟量表(VAS)在术前和术后 1 年测量症状负担。进一步进行生存分析,以 Kaplan-Meier 绘图呈现 Revision 无失败生存。
确定了 84 名合格患者,所有患者在初次手术后 VAS 均有显著改善。5 年 Revision 率为 19.05%,Revision 手术的平均时间为术后 25.31±17.11 个月。过敏性鼻炎(OR=9.287;p=0.011)和 LMS(OR=1.29;p=0.06)被发现是 Revision 手术的独立危险因素。LMS 对 Revision 手术的判别能力尚可(AUC=0.79),最佳截断值位于 LMS>13.5。同时患有过敏性鼻炎和 LMS≧14 的患者与总体生存率相比,Revision 无失败生存率仅为一半(38.1% vs. 80.95%,p<0.001)。
在患有 CRSwNP 且同时患有过敏性鼻炎和术前 LMS 较高的患者中,可能表明疾病处于晚期状态,最终在长期随访后 Revision 手术的风险较高。基于结果的分期系统将有助于改善 CRSwNP 的预后。